Business and Organization (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
Aug. 31, 2015
USD ($)
$ / shares
shares
|
May. 31, 2015
USD ($)
$ / shares
shares
|
Dec. 31, 2015
person
|
|
Bio-Reference Laboratories, Inc. | |||
Business Acquisition [Line Items] | |||
Common stock value | $ 2,259 | ||
Total purchase price | $ 950,148 | ||
EirGen Pharma Limited | |||
Business Acquisition [Line Items] | |||
Common stock value | $ 33,600 | ||
Total purchase price | 133,800 | ||
Total purchase price | $ 100,200 | ||
Common Stock | |||
Business Acquisition [Line Items] | |||
Stock price | $ / shares | $ 12.38 | $ 13.88 | |
Common Stock | Bio-Reference Laboratories, Inc. | |||
Business Acquisition [Line Items] | |||
Common stock received, in shares | shares | 76,566,147 | ||
Acquired entity share price | $ / shares | $ 34.05 | ||
Common Stock | EirGen Pharma Limited | |||
Business Acquisition [Line Items] | |||
Common stock received, in shares | shares | 2,420,487 | ||
Diagnostics | |||
Business Acquisition [Line Items] | |||
Sales force, persons | person | 420 |
X | ||||||||||
- Definition Number of Sales Employees No definition available.
|
X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|